InChI=1S/C43H76O5/c1- 3- 5- 7- 9- 11- 13- 15- 17- 19- 21- 23- 25- 27- 29- 31- 33- 35- 37- 42(45) 47- 40- 41(39- 44) 48- 43(46) 38- 36- 34- 32- 30- 28- 26- 24- 22- 20- 18- 16- 14- 12- 10- 8- 6- 4- 2/h12,14,18,20,24,26,30,32,41,44H,3- 11,13,15- 17,19,21- 23,25,27- 29,31,33- 40H2,1- 2H3/b14- 12- ,20- 18- ,26- 24- ,32- 30- /t41- /m0/s1 |
OUGXERRDRINUQU-AICYSBPGSA-N |
CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC |
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via diacylglycerol 40:4 )
Saccharomyces cerevisiae metabolite
Any fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae ).
(via diglyceride )
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via diglyceride )
|
|
View more via ChEBI Ontology
(2S)- 1- hydroxy- 3- (icosanoyloxy)propan- 2- yl (5Z,8Z,11Z,14Z)- icosa- 5,8,11,14- tetraenoate
|
1,2-DG 20:0/20:4(ω-6)
|
SUBMITTER
|
1-Arachidonyl-2-arachidonoyl-sn-glycerol
|
HMDB
|
1-arachidoyl-2-arachidonoyl-sn-glycerol
|
ChEBI
|
1-eicosanoyl-2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycerol
|
UniProt
|
1-eicosanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol
|
LIPID MAPS
|
1-icosanoyl-2-(5Z,8Z,11Z,14Z)-icosatetraenoyl-sn-glycerol
|
SUBMITTER
|
1-icosanoyl-2-[(5Z,8Z,11Z,14Z)-icosatetraenoyl]-sn-glycerol
|
ChEBI
|
DAG(20:0/20:4)
|
HMDB
|
DAG(20:0/20:4n6)
|
HMDB
|
DAG(20:0/20:4ω6)
|
HMDB
|
DAG(20:0/20:4w6)
|
HMDB
|
DAG(40:4)
|
HMDB
|
DG(20:0/20:4(5Z,8Z,11Z,14Z)/0:0)
|
LIPID MAPS
|
DG(20:0/20:4)
|
HMDB
|
DG(20:0/20:4/0:0)
|
LIPID MAPS
|
DG(20:0/20:4n6)
|
HMDB
|
DG(20:0/20:4ω6)
|
HMDB
|
DG(40:4)
|
HMDB
|
Diacylglycerol(20:0/20:4)
|
HMDB
|
Diacylglycerol(20:0/20:4n6)
|
HMDB
|
Diacylglycerol(20:0/20:4ω6)
|
HMDB
|
Diacylglycerol(20:0/20:4w6)
|
HMDB
|
Diacylglycerol(40:4)
|
HMDB
|
20671299
|
PubMed citation
|
Europe PMC
|
|